Quidel Reports Second Quarter 2019 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 2019. Second Quarter 2019 Highlights Total revenue increased 5% to $108.3 million, and on a constant currency basis grew 7%, as compared to $103.2 million in the second quarter of 2018. Cardiac Immunoassay revenue was $68.0 million on a reported bas